We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

140 hedge funds and large institutions have $1.13B invested in Immunogen Inc in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $3.78M

70% more capital invested

Capital invested by funds: $665M → $1.13B (+$467M)

2% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 44

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

1% less funds holding

Funds holding: 141140 (-1)

Holders
140
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
3.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
45
Reduced
44
Closed
23
Calls
$6.99M
Puts
$3.78M
Net Calls
+$3.2M
Net Calls Change
-$1.59M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
51
BlackRock Advisors
Delaware
$1.42M +$472K +43,016 +78%
State Board of Administration of Florida Retirement System
52
State Board of Administration of Florida Retirement System
Florida
$1.34M +$44.4K +4,045 +5%
SGAM
53
Smith Group Asset Management
Texas
$1.34M +$19.7K +1,790 +2%
PIM
54
Platinum Investment Management
Australia
$1.3M
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$1.3M +$993K +90,363 New
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$1.28M -$65.8K -5,990 -6%
AA
57
ALPS Advisors
Colorado
$1.23M +$470K +42,752 +100%
BG
58
BlackRock Group
United Kingdom
$1.21M +$76.1K +6,927 +9%
ProShare Advisors
59
ProShare Advisors
Maryland
$1.15M -$68.3K -6,219 -7%
Bank of America
60
Bank of America
North Carolina
$1.05M +$556K +50,647 +229%
DADC
61
D.A. Davidson & Co
Montana
$1.04M -$231K -21,035 -23%
NI
62
Numeric Investors
Massachusetts
$1.02M +$780K +71,000 New
Neuberger Berman Group
63
Neuberger Berman Group
New York
$996K +$78.4K +7,136 +11%
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$940K -$43.4K -3,950 -6%
TC
65
TFS Capital
Pennsylvania
$896K -$461K -41,970 -40%
UBS AM
66
UBS AM
Illinois
$830K -$14.3K -1,300 -2%
AIG
67
American International Group
New York
$827K -$43.4K -3,953 -6%
NFA
68
Nationwide Fund Advisors
Ohio
$803K -$78.9K -7,186 -11%
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$743K +$27.7K +2,525 +5%
UBS Group
70
UBS Group
Switzerland
$732K -$87.6K -7,973 -14%
VOYA Investment Management
71
VOYA Investment Management
Georgia
$686K
V
72
Veritable
Delaware
$648K -$54.1K -4,928 -10%
RFC
73
Russell Frank Company
Washington
$629K -$1.66M -151,183 -78%
QIM
74
Quantitative Investment Management
Virginia
$621K +$340K +31,000 +254%
PPA
75
Parametric Portfolio Associates
Washington
$607K +$13K +1,181 +3%

IMGN Hedge Fund Activity: Q2 2015 in Review

140 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2015, worth a combined $1.13B — up 70% from $665M a quarter earlier.

Fund positioning in IMGN was balanced in Q2 2015: 23 funds opened new positions, 23 closed out, 45 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $33.3M. The largest seller was BB Biotech, exiting entirely with an estimated $25.4M sold.

  • 140 institutional investors held Immunogen Inc (IMGN) as of Q2 2015, down from 141 in Q1 2015.
  • Funds reported $1.13B of Immunogen Inc stock for Q2 2015, up 70% quarter-over-quarter.
  • 23 funds opened new Immunogen Inc positions in Q2 2015 and 23 closed out, a net change of 0 holders.
  • The largest Immunogen Inc buyer in Q2 2015 was Millennium Management, an estimated $33.3M added.
  • The largest Immunogen Inc seller in Q2 2015 was BB Biotech, an estimated $25.4M sold.

Based on aggregated 13F filings for Q2 2015.